NASDAQ:CVAC
Delisted

Curevac N.v Stock Signals

etoro logo Buy CVAC
*Your capital is at risk
$4.66
+0 (+0%)
At Close: Apr 02, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Curevac N.V.

General

Signal Type Signal Value Data
Score 0.000 60 days ( 0 %
Last Price $4.66 0 %
Performance History
7 Days
$4.66 $4.66
0%
30 Days
$4.66 $4.66
0%
12 Mos
$2.86 $4.66
62.94%

2/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $4.66 - $4.66
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Apr 01, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Jan 20, 2026 - 52 days
Short MA 3 mos Sell Low Jan 09, 2026 - 58 days
Long MA 3 mos Sell Medium Feb 20, 2026 - 30 days
Short/Long MA 3 mos Sell Medium Feb 20, 2026 - 30 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 25.98
Signal Type Signal Value Importance Data
Trend - 12 mos 12.28 % Very High Width: 88.48 %
Pred. range - 12 mos $3.66 - $6.90 High -21.47 % - 48.01 %
Short MA 12 mos Sell Very High Jan 30, 2026 - 44 days
Long MA 12 mos Sell Very High Nov 28, 2025 - 86 days
Short/Long MA 12 mos Sell Very High Oct 29, 2025 - 107 days
Pivot Long Sell Low Jan 02, 2026 - 63 days
RSI Long Pivot Signal Sell Low Jan 29, 2026 - 45 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT CUREVAC N.V.
Curevac N.V
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 cli...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE